| Ytd | 11.43% | |
| 1y | 26.68% |
| Open | 9.29 | Prev Close | 9.38 | Low | 8.99 | High | 9.45 | Mkt Cap | 168.05M |
| Vol | 441.38K | Avg Vol | 485.48K | EPS | -5.74 | P/E | N/A | Forward P/E | -2.51 |
| Beta | 2.56 | Short Ratio | 8.28 | Inst. Own | 105.21% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 9.29 | 200-d Avg | 10.19 | 1yr Est | 56.78 |
Mizuho analyst Graig Suvannavejh maintains Corbus Pharmaceuticals (NASDAQ:CRBP) with a Outperform
Oppenheimer analyst Jeff Jones maintains Corbus Pharmaceuticals (NASDAQ:CRBP) with a Outperform a